These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17555386)

  • 1. Lymph node density: surrogate marker for quality of resection in bladder cancer?
    Kamat AM; Fisher MB
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):777-9. PubMed ID: 17555386
    [No Abstract]   [Full Text] [Related]  

  • 2. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concept of lymph node density--is it ready for clinical practice?
    Herr HW
    J Urol; 2007 Apr; 177(4):1273-5; discussion 1275-6. PubMed ID: 17382708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.
    Thompson IM
    J Urol; 2001 Aug; 166(2):630. PubMed ID: 11458100
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymph node assessment and lymphadenectomy in bladder cancer.
    Sharir S; Fleshner NE
    J Surg Oncol; 2009 Mar; 99(4):225-31. PubMed ID: 19235178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the outcome for invasive bladder cancer: the debate regarding pelvic lymphadenectomy moves from if to how.
    Catto JW
    Eur Urol; 2011 May; 59(5):719-20. PubMed ID: 21367517
    [No Abstract]   [Full Text] [Related]  

  • 11. The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.
    Ide H; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    Jpn J Clin Oncol; 2008 May; 38(5):360-4. PubMed ID: 18490370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separate submission of standard lymphadenectomy in 6 packets versus en bloc lymphadenectomy in bladder cancer.
    Ather MH; Alam Z; Jamshaid A; Siddiqui KM; Sulaiman MN
    Urol J; 2008; 5(2):94-8. PubMed ID: 18592461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separating surgical quality from causality--gaining perspective in the debate on lymph node count and extent of lymphadenectomy.
    Gilbert SM
    Cancer; 2008 Jun; 112(11):2331-3. PubMed ID: 18383514
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lymphatic dissection in radical cystectomy].
    Komiakov BK; Sergeev AV; Fadeev VA
    Vopr Onkol; 2010; 56(5):508-13. PubMed ID: 21137228
    [No Abstract]   [Full Text] [Related]  

  • 15. Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy.
    Ozcan MF; Dizdar O; Canda AE; Balbay MD
    BJU Int; 2011 Jun; 107(12):2002-3; author reply 2003-4. PubMed ID: 21623942
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphadenectomy in bladder cancer: a review.
    Buscarini M; Josephson DY; Stein JP
    Urol Int; 2007; 79(3):191-9. PubMed ID: 17940349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
    Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF
    J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer.
    Bruins HM; Stein JP
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1091-101. PubMed ID: 18588454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
    Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
    Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.